Tier 2 — strong
Acute Responses to Creatine Monohydrate and L-Arginine, Alone and Combined, on Repeated-Sprint Power, Countermovement Jump Height, and Stroop Reaction Time in Recreationally Active Men: A Randomized Double-Blind Crossover Trial
Metabolites
2026
16(9):688
Bibliography
- PubMed
- PMID 42783813
- Trial registry
- View on ClinicalTrials.gov Registered trial — results not yet published in a peer-reviewed journal.
- Funding
- Supported by Princess Nourah bint Abdulrahman University Researchers Supporting Project PNURSP2026R286.
- Competing interests
- No explicit competing-interests statement was located in the accessible PubMed or publisher records during Biohack Blueprint's 2026-10-02 audit. This is an audit-status statement, not confirmation that no competing interests existed.
Study snapshot
| Design | Randomized double-blind four-period crossover trial |
|---|---|
| Model | Human |
| Sample | 18 recreationally active men |
| Intervention | Placebo, creatine monohydrate 0.3 g/kg, L-arginine 6 g, or combined L-arginine plus creatine; testing 60 minutes after ingestion |
| Duration | Acute crossover sessions |
| Endpoints | Repeated-sprint average power; Repeated-sprint peak power; Countermovement jump; Stroop reaction time |
What the study showed, in plain terms
Key findings
What this study can and cannot tell us
Citation network
Articles citing this research paper
Biohack Blueprint analyses that reference this study in their evidence base.
Editorial review
Reviewed by the Biohack Blueprint research team
Last verified

